SUSAN PALDINO: Open Payments
NPI 1689018582 · MONROE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 21 payments from 9 companies in 2025. Trend: 2023 $46 · 2024 $205 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $150 |
| Exact Sciences Corporation | 2 | $50 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| InSightec,Inc | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Ozempic, Cologuard Collection Kit, ELIQUIS, MOUNJARO, BREZTRI, Exablate, UBRELVY, XIFAXAN.
Industry payments across CT — which companies pay providers there.
